Cargando…

P1264: HEMATOPOIETIC CLONES WITH TP53 MUTATIONS EXPAND IN PATIENTS WITH MCL DURING LENALIDOMIDE-BASED THERAPY

Detalles Bibliográficos
Autores principales:	Husby, S., Bæch-Laursen, C., Favero, F., Jespersen, J. S., Eskelund, C. W., Hutchings, M., Pedersen, L. B., Niemann, C. U., Weischenfeldt, J., Geisler, C., Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M., Grønbæk, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431177/ http://dx.doi.org/10.1097/01.HS9.0000847920.76280.3e

Ejemplares similares

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3
por: Eskelund, Christian Winther, et al.
Publicado: (2020)

Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
por: Lokhande, Lavanya, et al.
Publicado: (2021)

p53 is associated with high‐risk and pinpoints TP53 missense mutations in mantle cell lymphoma
por: Rodrigues, Joana M., et al.
Publicado: (2020)

Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established high-risk factors
por: Gerdtsson, Anna Sandström, et al.
Publicado: (2022)

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study
por: Nordström, Lena, et al.
Publicado: (2014)

Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity
por: Freiburghaus, Catja, et al.
Publicado: (2018)

Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide
por: Albertsson-Lindblad, Alexandra, et al.
Publicado: (2019)

Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
por: Lokhande, Lavanya, et al.
Publicado: (2020)

Propagación de gibberella fujikuroi ATCC 1264
por: Hernández Ruiz, Norma Griselda
Publicado: (1987)

1264. Healthcare-Acquired Influenza in Critical Ill Patients
por: Gutierrez, Valentina, et al.
Publicado: (2018)

Correction to Lancet Glob Health 2020; 8: e1264–72
Publicado: (2020)

Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
por: Sperling, Adam S., et al.
Publicado: (2022)

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
por: Nikkarinen, Anna, et al.
Publicado: (2023)

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
por: Ferrero, Simone, et al.
Publicado: (2023)

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
por: Ferrero, Simone, et al.
Publicado: (2020)

Statistiques AA: Run 86/3 : du 12.6.4 au 23.8.1986
por: Renaud, Y
Publicado: (1986)

Statistiques AA: Run 86/3 : du 12.6.4 au 23.8.1986
por: Renaud, Y
Publicado: (1986)

Ultrasonographical, clinical and histopathological features of 1264 nodules with papillary thyroid carcinoma and microcarcinoma based on tumor size
por: Seyrek, Neslihan Cuhaci, et al.
Publicado: (2020)

S221: LONG-TERM RESULTS OF THE FIL MCL0208 TRIAL COMPARING LENALIDOMIDE MAINTENANCE (LEN) VS OBSERVATION (OBS) AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MANTLE CELL LYMPHOMA (MCL)
por: Ladetto, Marco, et al.
Publicado: (2023)

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)
por: Wang, Michael, et al.
Publicado: (2017)

Prospective subgroup analyses of the randomized MCL‐002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma
por: Arcaini, Luca, et al.
Publicado: (2017)

1264. Characterization of HIV-Positive Patients with Low-Level Viremia in a Community HIV Clinic Between 2014 and 2018
por: Sanchez, Eduardo, et al.
Publicado: (2019)

1264. Rewrite The SAARs; Experience Implementing Optimized SAAR/AU Dashboards Across a 10 Hospital Health-System
por: Rondeau, Hunter O, et al.
Publicado: (2023)

Purported Mcl-1 inhibitor marinopyrrole A fails to show selective cytotoxicity for Mcl-1-dependent cell lines
por: Eichhorn, J M, et al.
Publicado: (2013)

Run 1260 and 1264 - Rings 1 & 2 - 26 GeV, Stacking in both rings and physics test for the DL machine
por: Risselada, Thys, et al.
Publicado: (1982)

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
por: Geyer, Mark B., et al.
Publicado: (2023)

Identification of unique and shared mitochondrial DNA mutations in neurodegeneration and cancer by single-cell mitochondrial DNA structural variation sequencing (MitoSV-seq)
por: Jaberi, Elham, et al.
Publicado: (2020)

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma
por: Lund, Johan, et al.
Publicado: (2018)

Unique post-translational oxime formation in the biosynthesis of the azolemycin complex of novel ribosomal peptides from Streptomyces sp. FXJ1.264
por: Liu, Ning, et al.
Publicado: (2016)

Erratum: Ali et al. In Utero Fetal Weight in Pigs Is Regulated by microRNAs and Their Target Genes. Genes 2021, 12, 1264
por: Ali, Asghar, et al.
Publicado: (2021)

Visfatin-Induced Inhibition of miR-1264 Facilitates PDGF-C Synthesis in Chondrosarcoma Cells and Enhances Endothelial Progenitor Cell Angiogenesis
por: Song, Chang-Yu, et al.
Publicado: (2022)

Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment
por: Brieghel, Christian, et al.
Publicado: (2019)

Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins
por: Soerensen, Mette, et al.
Publicado: (2022)

Correction: Unique post-translational oxime formation in the biosynthesis of the azolemycin complex of novel ribosomal peptides from Streptomyces sp. FXJ1.264
por: Liu, Ning, et al.
Publicado: (2016)

LncRNA SOCS2-AS1 inhibits progression and metastasis of colorectal cancer through stabilizing SOCS2 and sponging miR-1264
por: Zheng, Zhihai, et al.
Publicado: (2020)

Lenalidomide-Associated ITP
por: Herold, Christina I., et al.
Publicado: (2011)

PB2105: LENALIDOMIDE MAINTENANCE IN MULTIPLE MYELOMA: A RETROSPECTIVE, NATIONWIDE, REAL-WORLD STUDY
por: Harsløf, Mads, et al.
Publicado: (2023)

1264. Assessment of In Vivo Efficacy of CF-296 in addition to Vancomycin (VAN) and Daptomycin (DAP) against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model
por: Asempa, Tomefa E, et al.
Publicado: (2020)

Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
por: Xing, Lijie, et al.
Publicado: (2021)

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017
por: Albertsson-Lindblad, Alexandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gssdgrsjeaijmk4ci35bqc0bvi